Cargando…

Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs

Chronic hepatitis C virus (HCV) infection is associated with altered metabolism, including dyslipidemia and insulin resistance. These contribute to disease progression and influences the response to therapy. To investigate the relationships of new direct-acting antiviral drugs, simeprevir/sofosbuvir...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Sagheer, Ghada, Soliman, Elwy, Ahmad, Asmaa, Hamdy, Lamiaa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827781/ https://www.ncbi.nlm.nih.gov/pubmed/29451090 http://dx.doi.org/10.1080/19932820.2018.1435124

Ejemplares similares

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents
por: El Sagheer, Ghada M, et al.
Publicado: (2018)

Treatment of hepatitis C in HIV patients in the new DAA era
por: Soriano, Vicente
Publicado: (2014)

Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy
por: Drazilova, Sylvia, et al.
Publicado: (2018)

Telehealth for Hepatitis C Care in the DAA Era; Ensuring Everyone Can Access a Cure
por: Schulz, Thomas Ray, et al.
Publicado: (2017)

Treatment and re-treatment results of HCV patients in the DAA era
por: Piecha, Felix, et al.
Publicado: (2020)

Clinical significances and diagnostic utilities of both miR-215 and squamous cell carcinoma antigen-IgM versus alpha-fetoprotein in Egyptian patients with hepatitis C virus-induced hepatocellular carcinoma
por: Ali, Lamia H, et al.
Publicado: (2019)

Changing Landscape of Liver Transplantation in the Post-DAA and Contemporary ART Era
por: Saeed, Huma, et al.
Publicado: (2022)

Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA
por: Heidrich, Benjamin, et al.
Publicado: (2014)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs)
por: Ghanem, Samar, et al.
Publicado: (2023)

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
por: Hong, Chun-Ming, et al.
Publicado: (2021)

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
por: Amer, Fatma, et al.
Publicado: (2019)

Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C
por: El-Mesallamy, Hala O., et al.
Publicado: (2011)

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
por: Seo, Kwang Il, et al.
Publicado: (2017)

Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile
por: Shahbah, Doaa, et al.
Publicado: (2016)

Effect of dietary calcium and phosphorus levels on growth, carcass characteristics and liver and kidney functions of growing Egyptian geese
por: Alagawany, Mahmoud, et al.
Publicado: (2021)

Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?
por: Petta, Salvatore, et al.
Publicado: (2012)

310. Disparities in Hepatitis C Linkage to Care in the DAA Era: Findings from a Referral Clinic with an Embedded Nurse Navigator Model
por: Sherbuk, Jacqueline, et al.
Publicado: (2019)

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era
por: Busschots, Dana, et al.
Publicado: (2021)

Asymptomatic Atherosclerosis in Egyptian Rheumatoid Arthritis Patients and Its Relation to Disease Activity
por: Elshereef, Rawhya R., et al.
Publicado: (2015)

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
por: Emara, Mohamed H, et al.
Publicado: (2010)

Linkage and retention in HCV care for HIV‐infected populations: early data from the DAA era
por: Sacks‐Davis, Rachel, et al.
Publicado: (2018)

Genetic susceptibility for insulin resistance among Egyptian women
por: Zaki, Moushira Errfan, et al.
Publicado: (2016)

PIK3CA mutations in HER2-positive Breast Cancer Patients; Frequency and Clinicopathological Perspective in Egyptian Patients
por: Elwy, Fatma, et al.
Publicado: (2017)

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4
por: Rizk, Hanan H., et al.
Publicado: (2016)

Vitamin D and Nonskeletal Complications among Egyptian Sickle Cell Disease Patients
por: Hamdy, Mona, et al.
Publicado: (2018)

HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly
por: Brozzetti, Stefania, et al.
Publicado: (2021)

Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients
por: Dawood, Reham M., et al.
Publicado: (2022)

Location of the Maxillary Posterior Tooth Apices to the Sinus Floor in an Egyptian Subpopulation Using Cone-beam Computed Tomography
por: Ragab, Mai Hamdy, et al.
Publicado: (2022)

Insulin Resistance, Steatosis, and Fibrosis in Egyptian Patients with Chronic Hepatitis C Virus Infection
por: Ahmed, Ahlam M., et al.
Publicado: (2011)

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
por: Aebi-Popp, Karoline, et al.
Publicado: (2016)

“Waiting for DAAs”: A retrospective chart review of patients with untreated hepatitis C in Rwanda
por: Gupta, Neil, et al.
Publicado: (2017)

Perceived Stress in Hepatitis C Virus Infected Patients under the DAA-Based Therapy
por: Danilescu, Claudia Monica, et al.
Publicado: (2022)

Impact of IL12B Gene rs 3212227 Polymorphism on Fibrosis, Liver Inflammation, and Response to Treatment in Genotype 4 Egyptian Hepatitis C Patients
por: Youssef, Samar Samir, et al.
Publicado: (2013)

The role of hepatic progenitor cells in predicting response to therapy in Egyptian patients with chronic hepatitis C, genotype 4
por: Helal, Thanaa El A, et al.
Publicado: (2019)

Expression of chemerin correlates with a poor prognosis in female breast cancer patients
por: El-Sagheer, Ghada, et al.
Publicado: (2018)

Persistence of Cryoglobulinemic Vasculitis after DAA Induced HCV Cure
por: Danishwar, Mahmood, et al.
Publicado: (2022)

Evaluation of Multiplex Nested Polymerase Chain Reaction for Routine Hepatitis C Virus Genotyping in Egyptian Patients
por: Shemis, Mohamed Abbas, et al.
Publicado: (2012)

Genotype Mutations in Egyptian Children with Familial Mediterranean Fever: Clinical Profile, and Response to Colchicine
por: Talaat, Hala S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hdqv9ao0412g180runs0ahth55